Saltar al contenido
Merck

[Protease inhibitors as immunomodulators in experimental acute pancreatitis and staphylococcal infection].

Zhurnal mikrobiologii, epidemiologii, i immunobiologii (1993-01-01)
G A Chalyĭ, L G Prokopenko, N A Latysh
RESUMEN

The influence of protease-inhibiting preparations on the development of humoral immune response in diseases involving the development of secondary immunodeficiency (experimentally induced acute pancreatitis and staphylococcal infection) has been studied. Five injections of contrycal and epsilon-aminocaproic acid (epsilon-ACA), starting from day 1 after the induction of acute pancreatitis, normalized the immune response induced by sheep red blood cells 24 hours after operation. In staphylococcal infection protease-inhibiting preparations (contrycal, epsilon-ACA, Amben) produced a protective effect, increasing the survival rate and the mean survival time of the animals infected with staphylococci.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
4-(Aminomethyl)benzoic acid, 97%